Skip to main content
. 2022 May 26;14(11):2208. doi: 10.3390/nu14112208

Table 2.

Effects of STE on the contents of main fecal SCFAs.

Groups SCFAs (μg/g)
Acetic Acid Propanoic Acid Isobutyric Acid Butyric Acid Isovaleric Acid Valeric Acid Caproic Acid
NC 995.89 ± 80.17 b 220.89 ± 21.03 b 25.86 ± 1.64 a 365.12 ± 88.77 a 20.45 ± 2.16 a 42.29 ± 1.87 a 1.48 ± 0.51 a
MC 1307.18 ± 101.68 a 290.96 ± 34.29 a 13.76 ± 0.40 b 139.97 ± 23.48 b 10.60 ± 0.28 b 31.38 ± 1.48 b 0.82 ± 0.17 b
SASP 918.04 ± 137.65 b 250.71 ± 25.97 ab 16.44 ± 2.26 b 179.87 ± 29.07 b 12.29 ± 0.59 b 27.73 ± 0.56 b 0.80 ± 0.05 b
L-STE 907.52 ± 171.62 b 269.21 ± 12.53 a 16.54 ± 1.62 b 301.65 ± 22.48 a 11.92 ± 1.08 b 32.92 ± 2.22 b 0.84 ± 0.03 b
H-STE 879.19 ± 121.77 b 286.76 ± 27.32 a 14.91 ± 2.07 b 315.01 ± 27.28 a 11.63 ± 0.76 b 29.25 ± 6.62 b 0.84 ± 0.07 b

Abbreviations: NC, normal control group; MC, DSS-induced UC model group; SASP, suffasalarin intervention group at the dose of 100 mg/kg; L-STE, STE intervention group at the dose of 100 mg/kg; H-STE, STE intervention group at the dose of 400 mg/kg. Data are expressed as the mean ± the SD (n = 10) and analyzed by one-way ANOVA followed by Duncan’s multiple comparisons test. The different superscript lowercase letters in the same column indicate statistical significance (p < 0.05).